{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:02:50Z","timestamp":1781190170531,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260830"],"award-info":[{"award-number":["82260830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360842"],"award-info":[{"award-number":["82360842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kuang Haixue Expert Workstation of Yunnan Province","award":["202305AF150029"],"award-info":[{"award-number":["202305AF150029"]}]},{"name":"Young and Middle-Aged Academic and Technological Leader of Yunnan","award":["202405AC350042"],"award-info":[{"award-number":["202405AC350042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11399-w","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:27:46Z","timestamp":1763731666000},"page":"4541-4554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vasicine derivatives as potent MAPK inhibitors for psoriasis treatment"],"prefix":"10.1007","volume":"30","author":[{"given":"Qing-Yan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"11399_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.12968\/bjon.2024.0112","volume":"33","author":"M Perry","year":"2024","unstructured":"Perry M (2024) Psoriasis: an overview. Br J Nurs 33:686\u2013692. https:\/\/doi.org\/10.12968\/bjon.2024.0112","journal-title":"Br J Nurs"},{"key":"11399_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Blauvelt A, Duffin CK, Huang YH, Savage LJ, Guo L, Merola JF (2025) Psoriasis. Rev Dis Primers 11:45. https:\/\/doi.org\/10.1038\/s41572-025-00630-5","journal-title":"Rev Dis Primers"},{"key":"11399_CR3","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.jid.2024.09.012","volume":"144","author":"SM Lwin","year":"2024","unstructured":"Lwin SM, Azrielant S, He J, Griffiths CEM (2024) Curing psoriasis. J Invest Dermatol 144:2645\u20132649. https:\/\/doi.org\/10.1016\/j.jid.2024.09.012","journal-title":"J Invest Dermatol"},{"key":"11399_CR4","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.3390\/jcm13247549","volume":"13","author":"AI Butacu","year":"2024","unstructured":"Butacu AI, Toma C, Negulet IE, Manole I, Banica AN, Plesea A, Badircea IA, Iancu I, Tiplica GS (2024) Updates on psoriasis in special areas. J Clin Med 13:7549. https:\/\/doi.org\/10.3390\/jcm13247549","journal-title":"J Clin Med"},{"key":"11399_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118067","volume":"119","author":"Z Jin","year":"2025","unstructured":"Jin Z, Li G, He D, Chen J, Zhang Y, Li M, Yao H (2025) An overview of small-molecule agents for the treatment of psoriasis. Bioorg Med Chem 119:118067. https:\/\/doi.org\/10.1016\/j.bmc.2025.118067","journal-title":"Bioorg Med Chem"},{"key":"11399_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117904","volume":"297","author":"D Zhang","year":"2025","unstructured":"Zhang D, Miao X, Liu P, Liu H, Li C, Liu Y, Sun Y (2025) Small molecular inhibitors targeting Janus kinases (JAKs) for the treatment of psoriasis. Eur J Med Chem 297:117904. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117904","journal-title":"Eur J Med Chem"},{"key":"11399_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jad.2024.08.077","volume":"365","author":"M Wang","year":"2024","unstructured":"Wang M, Sun Y, Sun Y (2024) Efficacy and safety of drugs for psoriasis patients with mental disorders: a systematic review. J Affect Disord 365:112\u2013125. https:\/\/doi.org\/10.1016\/j.jad.2024.08.077","journal-title":"J Affect Disord"},{"key":"11399_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung YT, Aziz F, Guerrero-Castilla A, Arguelles S (2018) Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des 24:1449\u20131484. https:\/\/doi.org\/10.2174\/1381612824666180327165604","journal-title":"Curr Pharm Des"},{"key":"11399_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155122","volume":"254","author":"S Saleem","year":"2024","unstructured":"Saleem S (2024) Targeting MAPK signaling: a promising approach for treating inflammatory lung disease. Pathol Res Pract 254:155122. https:\/\/doi.org\/10.1016\/j.prp.2024.155122","journal-title":"Pathol Res Pract"},{"key":"11399_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112261","volume":"134","author":"Q Long","year":"2024","unstructured":"Long Q, Ma T, Wang Y, Chen S, Tang S, Wang T, Zhou Y, Xu K, Wan P, Cao Y (2024) Orientin alleviates the inflammatory response in psoriasis like dermatitis in BALB\/c mice by inhibiting the MAPK signaling pathway. Int Immunopharmacol 134:112261. https:\/\/doi.org\/10.1016\/j.intimp.2024.112261","journal-title":"Int Immunopharmacol"},{"key":"11399_CR11","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.24976\/discov.med.202436189.186","volume":"36","author":"YP An","year":"2024","unstructured":"An YP, Zhang Q, Ren Y, Yang S, Zhang Q (2024) BML-111 modulates and alleviates p38\/MAPK signaling pathway and Th1\/Th2\/Th17 cytokine response in murine psoriasis-like dermatitis. Discov Med 36:2026\u20132036. https:\/\/doi.org\/10.24976\/discov.med.202436189.186","journal-title":"Discov Med"},{"key":"11399_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/13543776.2020.1749263","volume":"30","author":"V Haller","year":"2020","unstructured":"Haller V, Nahidino P, Forster M, Laufer SA (2020) An updated patent review of p38 MAP kinase inhibitors (2014\u20132019). Expert Opin Ther Pat 30:453\u2013466. https:\/\/doi.org\/10.1080\/13543776.2020.1749263","journal-title":"Expert Opin Ther Pat"},{"key":"11399_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/13543776.2023.2242584","volume":"33","author":"VR Wydra","year":"2023","unstructured":"Wydra VR, Ditzinger RB, Seidler NJ, Hacker FW, Laufer SA (2023) A patent review of MAPK inhibitors (2018 - present). Expert Opin Ther Pat 33:421\u2013444. https:\/\/doi.org\/10.1080\/13543776.2023.2242584","journal-title":"Expert Opin Ther Pat"},{"key":"11399_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2025.103173","volume":"90","author":"M Anheyer","year":"2025","unstructured":"Anheyer M, Cramer H, Ostermann T, L\u00e4ngler A, Anheyer D (2025) Herbal medicine for treating psoriasis: a systematic review. Complement Ther Med 90:103173. https:\/\/doi.org\/10.1016\/j.ctim.2025.103173","journal-title":"Complement Ther Med"},{"key":"11399_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118166","volume":"330","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang CS, Zhang AL, Xue C, Lu C (2024) Chinese herbal medicine bath therapy for psoriasis vulgaris using topical calcipotriol as the comparator: a systematic review with meta-analysis and association rule analysis. J Ethnopharmacol 330:118166. https:\/\/doi.org\/10.1016\/j.jep.2024.118166","journal-title":"J Ethnopharmacol"},{"key":"11399_CR16","doi-asserted-by":"publisher","first-page":"30341","DOI":"10.34172\/bi.30341","volume":"15","author":"T Yadav","year":"2024","unstructured":"Yadav T, Yadav HKS, Raizaday A, Alam MS (2024) The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: a new approach. Bioimpacts 15:30341. https:\/\/doi.org\/10.34172\/bi.30341","journal-title":"Bioimpacts"},{"key":"11399_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113322","volume":"153","author":"A Basit","year":"2022","unstructured":"Basit A, Shutian T, Khan A, Khan SM, Shahzad R, Khan A, Khan S, Khan M (2022) Anti-inflammatory and analgesic potential ofleaf extract of Justicia adhatoda L. (Acanthaceae) in carrageenan and formalin-induced models by targeting oxidative stress. Biomed Pharmacother 153:113322. https:\/\/doi.org\/10.1016\/j.biopha.2022.113322","journal-title":"Biomed Pharmacother"},{"key":"11399_CR18","doi-asserted-by":"publisher","first-page":"109102","DOI":"10.1016\/j.clim.2022.109102","volume":"244","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Du W, Zhu D, Li M, Qu L, Rao G, Lin Y, Tong X, Sun Y, Huang, (2022) FVasicine alleviates 2,4-dinitrochlorobenzene-induced atopic dermatitis and passive cutaneous anaphylaxis in BALB\/c mice. Clin Immunol 244:109102. https:\/\/doi.org\/10.1016\/j.clim.2022.109102","journal-title":"Clin Immunol"},{"issue":"Pt A","key":"11399_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112996","volume":"142","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhu D, Kong L, Du W, Qu L, Yang Y, Rao G, Huang F, Tong X (2024) Vasicine attenuates atherosclerosis via lipid regulation, inflammation inhibition, and autophagy activation in ApoE-\/- mice. Int Immunopharmacol 142(Pt A):112996. https:\/\/doi.org\/10.1016\/j.intimp.2024.112996","journal-title":"Int Immunopharmacol"},{"key":"11399_CR20","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1021\/acs.jmedchem.7b00322","volume":"60","author":"M Ahmad","year":"2017","unstructured":"Ahmad M, Aga MA, Bhat JA, Kumar B, Rouf A, Capalash N, Mintoo MJ, Kumar A, Mahajan P, Mondhe DM, Nargotra A, Sharma PR, Zargar MA, Vishwakarma RA, Shah BA, Taneja SC, Hamid A (2017) Exploring derivatives of quinazoline alkaloid l-vasicine as cap groups in the design and biological mechanistic evaluation of novel antitumor histone deacetylase inhibitors. J Med Chem 60:3484\u20133497. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00322","journal-title":"J Med Chem"},{"key":"11399_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/727304","volume":"2015","author":"V Duraipandiyan","year":"2015","unstructured":"Duraipandiyan V, Al-Dhabi NA, Balachandran C, Ignacimuthu S, Sankar C, Balakrishna K (2015) Antimicrobial, antioxidant, and cytotoxic properties of vasicine acetate synthesized from vasicine isolated from Adhatoda vasica L. BioMed Res Int 2015:727304. https:\/\/doi.org\/10.1155\/2015\/727304","journal-title":"BioMed Res Int"},{"key":"11399_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0378-8741(95)01331-8","volume":"50","author":"JM Grange","year":"1996","unstructured":"Grange JM, Snell NJ (1996) Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J Ethnopharmacol 50:49\u201353. https:\/\/doi.org\/10.1016\/0378-8741(95)01331-8","journal-title":"J Ethnopharmacol"},{"key":"11399_CR23","doi-asserted-by":"publisher","first-page":"115145","DOI":"10.1016\/j.ejmech.2023.115145","volume":"249","author":"K Bhanukiran","year":"2023","unstructured":"Bhanukiran K, Krishnamurthy S, Singh SK, Hemalatha S (2023) Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 249:115145. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115145","journal-title":"Eur J Med Chem"},{"issue":"3 Pt B","key":"11399_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar RS, Gudjonsson JE, Ward NL (2022) Mouse models of psoriasis: a comprehensive review. J Invest Dermatol 142(3 Pt B):884\u2013897. https:\/\/doi.org\/10.1016\/j.jid.2021.06.019","journal-title":"J Invest Dermatol"},{"key":"11399_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8:437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6","journal-title":"Signal Transduct Target Ther"},{"key":"11399_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103748","volume":"98","author":"YL Tang","year":"2020","unstructured":"Tang YL, Zheng X, Qi Y, Pu XJ, Liu B, Zhang X, Li XS, Xiao WL, Wan CP, Mao ZW (2020) Synthesis and anti-inflammatory evaluation of new chalcone derivatives bearing bispiperazine linker as IL-1\u03b2 inhibitors. Bioorg Chem 98:103748. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103748","journal-title":"Bioorg Chem"},{"key":"11399_CR27","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182:5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"J Immunol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11399-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:33:09Z","timestamp":1779535989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11399-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11399"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11399-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}